Different outcome of six homozygotes for prothrombin A20210A gene variant

Journal of Translational Medicine

Volumn 6, Issue , 2008, Pages

  Di Micco, Pierpaolo ^a   Di Fiore, Rosanna ^b   Niglio, Alferio ^c   Quaranta, Sandro ^b   Angiolillo, Antonella ^d   Cardillo, Giuseppe ^b   Castaldo, Giuseppe ^b  

^a Fatebenefratelli Hospital of Naples   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c SECOND UNIVERSITY OF NAPLES   (Italy)

^d UNIVERSITY OF MOLISE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ORAL CONTRACEPTIVE AGENT; PROTHROMBIN;

ADULT; ANAMNESIS; ARTICLE; CEREBROVASCULAR ACCIDENT; CHRONIC HEPATITIS; CLINICAL ARTICLE; COLOR ULTRASOUND FLOWMETRY; COMPUTER ASSISTED TOMOGRAPHY; CONTRACEPTION; FEMALE; GENE IDENTIFICATION; GENETIC ANALYSIS; GENETIC COUNSELING; GENETIC PREDISPOSITION; GENETIC VARIABILITY; HEART INFARCTION; HIGH RISK PATIENT; HOMOZYGOSITY; HUMAN; INTERNATIONAL NORMALIZED RATIO; LIVER DISEASE; LOW DRUG DOSE; MALE; PREGNANCY COMPLICATION; PROTHROMBIN TIME; THROMBOSIS PREVENTION; VENOUS THROMBOEMBOLISM; CASE REPORT; ECHOGRAPHY; FEMORAL VEIN; FOLLOW UP; GENETICS; HOMOZYGOTE; MIDDLE AGED; POPLITEAL VEIN; SIBLING; THALAMUS; TIME; TREATMENT OUTCOME; VEIN THROMBOSIS;

ADULT; ANTICOAGULANTS; FEMALE; FEMORAL VEIN; FOLLOW-UP STUDIES; HOMOZYGOTE; HUMANS; MALE; MIDDLE AGED; POPLITEAL VEIN; PROTHROMBIN; SIBLINGS; THALAMUS; TIME FACTORS; TREATMENT OUTCOME; VARIATION (GENETICS); VENOUS THROMBOSIS;

EID: 48249119964     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/1479-5876-6-36     Document Type: Article

References (25)

1. Brown K Luddington R Williamson D Baker P Baglin T Risk of venous thromboembolism associated with a G to A transition at position 20210 in the 3′-untranslated region of the prothrombin gene Br J Haematol 1997, 98:907-909. 10.1046/j.1365-2141.1997.3093130.x 9326187
2. Hillarp A Zoller B Svensson PJ Dahlback B The 20210 allele of the prothrombin gene is a common risk factor among Swedish outpatients with verified deep venous thrombosis Thromb Haemost 1997, 78:990-992. 9308741
3. Bosler D Mattson J Crisan D Phenotypic heterogeneity in patients with homozygous prothrombin 20210 AA genotype. A paper from the 2005 William Beaumont Hospital Symposium on Molecular Pathology J Mol Diagn 2006, 8:420-425. 1867627 16931580 10.2353/jmoldx.2006.060014
4. Arruda VR Siquiera LH Chiaparini LC Coelho OR Mansur AP Ramires A Annichino-Bizzacchi JM Prevalence of the prothrombin gene variant 20210 G>A among patients with myocardial infarction Cardiovasc Res 1998, 37:42-45. 10.1016/S0008-6363(97)00211-3 9539856
5. The Atherosclerosis, Thrombosis and Vascular Biology Italian Study Group No evidence of association between prothrombotic gene polymorphisms and the development of acute myocardial infarction at a young age Circulation 2003, 107:1117-1125. 10.1161/01.CIR.0000051465.94572.D0 12615788
6. Ferraresi P Marchetti G Legnani C Cavallari E Castoldi E Mascoli F Ardissino D Palareti G Bernardi F The heterozygous 20210 G/A prothrombin genotype is associated with early venous trombosis in inherited thrombophilias and is not increased in frequency artery disease Arterioscler Thromb Vasc 1997, 17:2418-2422.
7. Dilley A Austin H Hooper WC El-Jamil M Whitsett C Wenger NK Benson J Evatt B Prevalence of the prothrombin 20210 G-to-A variant in blacks: infants, patients with venous thrombosis, patients with myocardial infarction, and control subjects J Lab Clin Med 1998, 132:444-445. 10.1016/S0022-2143(98)90121-4 9851730
8. Martinelli I Franchi F Akwan S Bettini P Merati G Mannucci PM The transition G to A at position 20210 in the 3′-untranslated region of the prothrombin gene is not associated with cerebral ischemia Blood 1997, 90:3806-3807. 9345069
9. Rosendaal FR Siscovick DS Schwartz SM Psaty BM Raghunathan TE Vos HL A common prothrombin variant (20210 G to A) increases the risk of myocardial infarction in young women Blood 1997, 90:1747-1750. 9292507
10. Ye Z Liu EH Higgins JP Keavney BD Lowe GD Collins R Danesh J Seven haemostatic gene polymorphisms in coronary disease: Meta-analysis of 66155 cases and 91307 controls Lancet 2006, 367:651-658. 10.1016/ S0140-6736(06)68263-9 16503463
11. Boinot C Borgel D Kitzis A Guicheteau M Aiach M Alhenc-Gelas M Familial thrombophilia is an oligogenetic disease: Involvement of the prothrombin G20210A, PROC and PROS gene mutations Blood Coagul Fibrinolysis 2003, 14:191-196. 10.1097/00001721-200302000-00012 12632031
12. Watzke HH Schüttrumpf J Graf S Huber K Panzer S Increased prevalence of a polymorphism in the gene coding for human prothrombin in patients with coronary heart disease Thrombosis Res 1997, 87:521-526. 10.1016/S0049-3848(97)00181-3 9330434
13. Doggen CJM Cats VM Bertina RM Rosendaal FR Interaction of coagulation defects and cardiovascular risk factors: Increased risk of myocardial infarction associated with Factor V Leiden or Prothrombin 20210A Circulation 1998, 97:1037-1041. 9531249
14. Corral J Gonzales-Conejero R Lozano ML Rivera J Heras I Vicente V The venous thrombosis risk factor 20210 A allele of the prothrombin gene is not a major risk factor for arterial thrombotic disease Br J Haematol 1997, 99:304-307. 10.1046/j.1365-2141.1997.3943208.x 9375745
15. Ridker PM Hennekens CH Miletich JP G20210A mutation in prothrombin gene and risk of myocardial infarction, stroke, and venous thrombosis in a large cohort of US men Circulation 1999, 99:999-1004. 10051291
16. Albers I Hartmann H Bircher J Creutzfeldt W Superiority of the Child-Pugh classification to quantitative liver function tests for assessing prognosis of liver cirrhosis Scand J Gastroenterol 1989, 24:269-276. 10.3109/00365528909093045 2734585
17. Martinelli I Risk factors in venous thromboembolism Thromb Haemost 2001, 86:395-403. 11487029
18. Di Micco P D'Uva M Strina I De Placido G Di Fiore R Quaranta S Castaldo G Recurrent pregnancy loss and thrombophilia Clin Lab 2007, 53:309-314. 17605406
19. Vandenbroucke JP Koster T Briët E Reitsma PH Bertina RM Rosendaal FR Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation Lancet 1994, 344:1453-7. 10.1016/S0140-6736(94)90286-0 7968118
20. Dawber TR Moore FE Mann GV Coronary heart disease in the Framingham Study Am J Pub Health 1957, 47:4-24. 13411327 1550985
21. Ejlersen E Melsen T Ingerslev J Andreasen RB Vilstrup H Recombinant activated factor VII (rFVIIa) acutely normalizes prothrombin time in patients with cirrhosis during bleeding from oesophageal varices Scand J Gastroenterol 2001, 36:1081-1085. 10.1080/003655201750422701 11589383
22. Cui R He J Zhang F Wang B Ding H Shen H Li Y Chen X Diagnostic value of protein induced by vitamin K absence (PIVKAII) and hepatoma-specific band of serum gamma-glutamyl transferase (GGTII) as hepatocellular carcinoma markers complementary to alpha-fetoprotein Br J Cancer 2003, 88:1878-1882. 10.1038/sj.bjc.6601018 12799630
23. Marrero JA Su GL Wei W Emick D Conjeevaram HS Fontana RJ Lok AS Des-gamma carboxyprothrombin can differentiate hepatocellular carcinoma from nonmalignant chronic liver disease in american patients Hepatology 2003, 37:1114-1121. 10.1053/jhep.2003.50195 12717392
24. Lecleire S Di Fiore F Merle V Hervé S Duhamel C Rudelli A Nousbaum JB Amouretti M Dupas JL Gouerou H Czernichow P Lerebours E Acute upper gastrointestinal bleeding in patients with liver cirrhosis and in noncirrhotic patients: Epidemiology and predictive factors of mortality in a prospective multicenter population-based study J Clin Gastroenterol 2005, 39:321-327. 10.1097/01.mcg.0000155133.50562.c9 15758627
25. Poort SR Rosendaal FR Reitsma PH Bertina RM A common genetic variation in the 3′-untraslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and increase in venous thrombosis Blood 1996, 88:3698-3703. 8916933